Sign up to our newsletter

Contact Us

PWSA USA conference goes online and open to all!

The PWSA USA’s national convention is going online from 22nd to 26th June, 2021. Over the course of five days, attendees will share ideas and experiences while learning from leaders in the field of PWS. The virtual format makes it possible for more families than...

IPWSO calls for use of Growth Hormone treatment in adults

IPWSO argues that Growth Hormone treatment should be universally available not just to children but also to adults with PWS. Our Clinical and Scientific Advisory Board has written to the Editor of the Orphanet Journal of Rare Diseases calling for the use of Growth...

Semaglutide trial results

A study published in the New England Journal of Medicine has shown exciting results from trials of a drug called semaglutide on people with severe obesity. The trial showed that people lost an average of 15kg when receiving semaglutide compared with only 2.6kg in...

Prader-Willi research

Our Clinical and Scientific Advisory Board has published a collated list of all PWS research papers published from October to December 2020. Download...
Addressing UHC through Rare Diseases

Addressing UHC through Rare Diseases

We attended the webinar “Addressing UHC through Rare Diseases” co-organised by Rare Diseases International and EURORDIS on 11th December 2020… The discussion included a lively exchange on the challenges and potential for Universal Health Coverage to...

We are recruiting!

The International Prader-Willi Syndrome Organisation is looking for a talented and motivated UK-based Project Manager to support its virtual training and meetings including the coordination and facilitation of a series of Project ECHO® telementoring initiatives...